![Erin Borger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erin Borger
Directeur Général chez ExThera Medical Corp.
Profil
Erin R.
Borger is currently the Chief Executive Officer & Director at ExThera Medical Corp.
Mr. Borger previously worked as a Director at the National Parkinson Foundation, Inc. Mr. Borger also served as an Independent Director at Longeveron, Inc. Mr. Borger completed their undergraduate degree at Wofford College.
Postes actifs de Erin Borger
Sociétés | Poste | Début |
---|---|---|
ExThera Medical Corp.
![]() ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Directeur Général | 15/11/2023 |
Anciens postes connus de Erin Borger
Sociétés | Poste | Fin |
---|---|---|
LONGEVERON INC. | Directeur/Membre du Conseil | 09/06/2023 |
National Parkinson Foundation, Inc. | Directeur/Membre du Conseil | - |
Formation de Erin Borger
Wofford College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LONGEVERON INC. | Health Technology |
Entreprise privées | 2 |
---|---|
National Parkinson Foundation, Inc. | Health Technology |
ExThera Medical Corp.
![]() ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Health Services |